Fortell AI Hearing Aids vs Otofonix Encore

The Fortell AI Hearing Aids are a premium prescription behind-the-ear device priced at $6,800, earning an A grade with a SoundScore of 6.0/5 in HearAdvisor lab testing—an exceptional result that places this device at the top of the prescription hearing aid category. Speech performance is where the Fortell AI truly distinguishes itself. Speech in noise scores an outstanding 6.0/5, a full 3.89 points above the category average of 2.11/5—the kind of margin that represents a meaningful difference in challenging listening environments like restaurants or group conversations. Speech in quiet also excels at 4.6/5, sitting 1.20 points above the category average. Music streaming performs strongly at 4.2/5, coming in 1.44 points above average for the category. The device does have a notable limitation: own-voice comfort scores just 1.5/5, falling 1.20 points below the category average. This low absolute score suggests wearers may notice occlusion effects when speaking. Feedback handling is excellent at 4.8/5, essentially matching the category average. Best suited for: Users who prioritize understanding speech in difficult listening situations and value streaming quality, and who can tolerate potential own-voice occlusion. Given the premium price point, buyers should weigh whether the exceptional speech-in-noise performance justifies the investment compared to alternatives like the Oticon Intent or Oticon Zeal, which offer strong performance at lower price points.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.